CN106282241A - The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 - Google Patents
The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 Download PDFInfo
- Publication number
- CN106282241A CN106282241A CN201610637401.7A CN201610637401A CN106282241A CN 106282241 A CN106282241 A CN 106282241A CN 201610637401 A CN201610637401 A CN 201610637401A CN 106282241 A CN106282241 A CN 106282241A
- Authority
- CN
- China
- Prior art keywords
- brachydanio rerio
- grna
- cas9
- sudden change
- bmp2a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 47
- 241000252212 Danio rerio Species 0.000 title claims abstract description 41
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 10
- 108020005004 Guide RNA Proteins 0.000 claims abstract description 25
- 238000013461 design Methods 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims abstract description 7
- 230000009471 action Effects 0.000 claims abstract description 4
- 230000008859 change Effects 0.000 claims description 24
- 108020004414 DNA Proteins 0.000 claims description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 10
- 210000001161 mammalian embryo Anatomy 0.000 claims description 10
- 230000001568 sexual effect Effects 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 7
- 238000009396 hybridization Methods 0.000 claims description 7
- 239000013612 plasmid Substances 0.000 claims description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000004087 circulation Effects 0.000 claims description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 230000027326 copulation Effects 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000002123 RNA extraction Methods 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 239000012154 double-distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 230000035772 mutation Effects 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000011535 reaction buffer Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 108091027544 Subgenomic mRNA Proteins 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 238000010459 TALEN Methods 0.000 description 2
- 108091028113 Trans-activating crRNA Proteins 0.000 description 2
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 108091079001 CRISPR RNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010010 raising Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses and obtain, by CRISPR/Cas9, the method that knocks out the Brachydanio rerio of bmp2a gene, devise new gRNA sequence, design is BMP2a first between exon and intron, and gRNA sequence is GGAGCCCATCACTAGACTCTTGG, and enzyme action is HinfI.The features such as knock out compared with the technology of gene with tradition, it is little that CRISPR/Cas9 technology has toxicity, and accuracy is high, and efficiency is high, and the success cycle is short;So in theory so that BMP2a gene faster must be knocked.
Description
Technical field
The method that the present invention relates to obtain knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9.
Background technology
A kind of adaptive immunity defence that CRISPR/Cas9 is antibacterial and archeobacteria is formed during long-term evolution, can
It is used for resisting virus and the foreign DNA of invasion.CRISPR/Cas9 system is by by invasion phage and the fragment of plasmid DNA
It is incorporated in CRISPR, and utilizes corresponding CRISPR RNAs(crRNAs) instruct the degraded of homologous sequence, thus immunity is provided
Property.The operation principle of this system is crRNA(CRISPR-derived RNA) by base pairing and tracrRNA(trans-
Activating RNA) combine formed tracrRNA/crRNA complex, this complex guide nuclease Cas9 albumen with
The sequence target site of crRNA pairing shears double-stranded DNA.And by engineer's both RNA, formation can be transformed and have and draw
Lead the sgRNA(short guide RNA of effect), it is sufficient to guide Cas9 that the fixed point of DNA is cut.Guide as a kind of RNA
DsDNA associated proteins, Cas9 effector nuclease is known first unified factor (unifying factor), it is possible to altogether
Location RNA, DNA and albumen, thus have huge transformation potentiality.Cas9(Cas9 by albumen Yu nuclease free
Nuclease-null) merge, and express suitable sgRNA, any dsDNA sequence can be targeted, and RNA may be connected to
The end of sgRNA, does not affect the combination of Cas9.Therefore, Cas9 can bring at any dsDNA sequence any fusion protein and
RNA, this is the research of organism and transformation brings great potential.Gene technology is struck, CRISPR/ compared to traditional Talens etc.
Cas9 has higher efficiency, more convenient operation, and advantage is as follows:
1, it is only necessary to synthesizing a sgRNA and can be achieved with the modification of the specificity to gene, Cas albumen does not have specificity.
2, the sequence of coding sgRNA is less than 100bp, therefore more simple and convenient than building TALENs and ZFNs.
3, the complication that the TALENs code carrier that shorter sgRNA sequence it also avoid overlength, height repeats brings.
Chinese patent 201510582860.5 discloses one and obtains knocking out Hepcidin-gene by CRISPR/Cas9 technology
The preparation method of Brachydanio rerio.So can utilize CRISPR/Cas9 technology, one section of PAM district that design is unique so that in Brachydanio rerio
BMP2a gene knocked out by perfection, the most " do not accidentally injure " other genes, form the Brachydanio rerio that the first BMP2a knocks out in the world?
Knock out model animal Brachydanio rerio significant of transgenic as the first BMP2a, BMP2a be regulation and control ferrum main because of
Element, is once knocked, i.e. success animal mould becomes the model animal that ferrum transships, and can get rid of anthropic factor intervention, for research ferrum
Expression study significant.
Summary of the invention
The technical problem to be solved in the present invention is to provide the Brachydanio rerio obtaining knocking out bmp2a gene by CRISPR/Cas9.
In order to solve above-mentioned technical problem, the present invention provides following technical scheme.
The method being obtained by CRISPR/Cas9 knocking out the Brachydanio rerio of bmp2a gene, is comprised the steps:
(1) devising new gRNA sequence, design is BMP2a first between exon and intron, and gRNA sequence is
GGAGCCCATCACTAGACTCTTGG, enzyme action is HinfI;
(2) designing and synthesizing gRNA primer, primer is shown in Table 1:
The primer sequence of table 1 CAS9BMP2a is the P3 of design:
Forward sequence (5’to3’):CCTCTTCAACCTGACCTCCA;
Reverse sequence (5’to 3’):GTCCGTCTGTGGTCCACTTT;
P3:GATCACTAATACGACTCACTATAGGAGCCCATCACTAGACTCTGTTTTAGAGC TAGAAAT;
P4:AAAAGCACCGACTCGGTGCC;
GRNA sequence GGAGCCCATCACTAGACTCTTGG;
(3) primer of design being carried out PCR, PCR system is as follows:
gRNA- plasmid 10 ng;
P3 1 ul(10 pmol);
P4 1 ul(10 pmol);
Buffer 10;
dNTP 8;
KOD 0.5;
ddH2O Up to 100 ul;
PCR reaction condition is: 95 DEG C of denaturations 3min, enters three steps circulations (95 DEG C of-20s, 58 DEG C of-20s, 72 DEG C of-20s totally 30
Individual circulation), then 72 DEG C of-10min, finally it is incubated at 16 DEG C;After electrophoresis detection PCR primer, it is purified;
(4) under the conditions of RNA-Free, gRNA being carried out in vitro transcription, system is:
2.5mmol/L NTP 4ul;
10× Reaction Buffer 2ul;
Template DNA 1 1ug(<6ul);
T7 Enzyme Mix 2ul;
DEPC Water up to 20ul ;
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul ;
37 ° of C of above system, 1 hour reaction is complete, is then purified;
(5) being expelled in single celled zebrafish embryo by the mRNA of aforementioned purification, extract RNA after 4 days, transcription DNA is carried out
Order-checking detection;Injection system is as follows:
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul;
After (6) three months after sexual maturity, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, obtain the heterozygosis of certain probability
Son, will carry out RNA extraction and is transcribed into DNA and send order-checking to check whether sudden change after embryo, DNA at this time is also
It it is double-strand;Then after cDNA with the 19T carrier finding the Brachydanio rerio of sudden change after order-checking being connected, by it in culture medium
Middle ball chart board, after 12-14 hour, the plasmid connected can be grown up with spotwise, after being chosen speckle, obtains
It is the DNA of strand, again send order-checking, finally give the sudden change of strand, then cultivated sexual maturity after growing up three months
After, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, check whether sudden change after obtaining embryo, by the Brachydanio rerio of sudden change
Support after choosing monoclonal order-checking;
(7), after three months after sexual maturity, the milter that the sudden change of the second filial generation is grown up excises tail again with raun, reflects
Fixed, refer to step (6), obtain the Brachydanio rerio copulation again of identical mutation (lacking several base), thus the BMP2a that obtains isozygotying strikes
The Brachydanio rerio removed.
Comprise the steps: as the purification process in the present invention one optimal technical scheme, step (3) and step (4)
(A) adding water and the phenol/chloroform/isopropanol that volume is 1:2-3, after mixing, 10,000-15,000 rpm is centrifuged
5min. upper strata moves into new pipe, repeats this step once;
(B) upper strata moves into new pipe, adds 150ul chloroform, centrifugal 5 min;
(C) 1/10 volume 2.5 M sodium acetate and 2.5 volume ethanol ,-70C freezing 30min are added;
(D) centrifugal 10,000-15,000rpm is at 4C 15min;
(E) discard solution and stay precipitation, add 200ul 80% ethanol, centrifugal 5 min, discard solution, use 10-20 l after drying
DEPC H2O dissolves.
Knock out compared with the technology of gene with tradition, it is little that CRISPR/Cas9 technology has toxicity, and accuracy is high, and efficiency is high, becomes
The features such as the merit cycle is short;So in theory so that BMP2a gene faster must be knocked.
Accompanying drawing explanation
Fig. 1 is the cultivation hybridization figure system of the inventive method.
Detailed description of the invention
Detailed description of the invention
This time in embodiment, primer used is the synthesis of Suzhou Jin Weizhi company.Wild-type zebrafish AB strain, Suzhou
University's biological clock research center.
Specific experiment process:
Design gRNA site-PCR-purification-in vitro transcription-purification-microinjection-identified activity-raisings is to the most adult-and wild type
Copulation-detection embryo of future generation cuts tail after whether carrying mutational site-raisings-adult and identifies Heterozygous mutants-two heterozygote
Copulation obtains Mutants homozygous.
The method being obtained by CRISPR/Cas9 knocking out the Brachydanio rerio of bmp2a gene, is comprised the steps:
(1) devising new gRNA sequence, design is BMP2a first between exon and intron, and gRNA sequence is
GGAGCCCATCACTAGACTCTTGG, enzyme action is HinfI;
(2) designing and synthesizing gRNA primer, primer is shown in Table 1:
The primer sequence of table 1 CAS9BMP2a is the P3 of design:
Forward sequence (5’to3’):CCTCTTCAACCTGACCTCCA;
Reverse sequence (5’to 3’):GTCCGTCTGTGGTCCACTTT;
P3:GATCACTAATACGACTCACTATAGGAGCCCATCACTAGACTCTGTTTTAGAGC TAGAAAT;
P4:AAAAGCACCGACTCGGTGCC;
GRNA sequence GGAGCCCATCACTAGACTCTTGG;
(3) primer of design being carried out PCR, PCR system is as follows:
gRNA- plasmid 10 ng;
P3 1 ul(10 pmol);
P4 1 ul(10 pmol);
Buffer 10;
dNTP 8;
KOD 0.5;
ddH2O Up to 100 ul;
PCR reaction condition is: 95 DEG C of denaturations 3min, enters three steps circulations (95 DEG C of-20s, 58 DEG C of-20s, 72 DEG C of-20s totally 30
Individual circulation), then 72 DEG C of-10min, finally it is incubated at 16 DEG C;After electrophoresis detection PCR primer, it is purified;
(4) under the conditions of RNA-Free, gRNA being carried out in vitro transcription, system is:
2.5mmol/L NTP 4ul;
10× Reaction Buffer 2ul;
Template DNA 1 1ug(<6ul);
T7 Enzyme Mix 2ul;
DEPC Water up to 20ul ;
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul ;
37 ° of C of above system, 1 hour reaction is complete, is then purified;
(5) being expelled in single celled zebrafish embryo by the mRNA of aforementioned purification, extract RNA after 4 days, transcription DNA is carried out
Order-checking detection;Injection system is as follows:
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul;
After (6) three months after sexual maturity, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, obtain the heterozygosis of certain probability
Son, will carry out RNA extraction and is transcribed into DNA and send order-checking to check whether sudden change after embryo, DNA at this time is also
It it is double-strand;Then after cDNA with the 19T carrier finding the Brachydanio rerio of sudden change after order-checking being connected, by it in culture medium
Middle ball chart board, after 12-14 hour, the plasmid connected can be grown up with spotwise, after being chosen speckle, obtains
It is the DNA of strand, again send order-checking, finally give the sudden change of strand, then cultivated sexual maturity after growing up three months
After, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, check whether sudden change after obtaining embryo, by the Brachydanio rerio of sudden change
Support after choosing monoclonal order-checking;
(7), after three months after sexual maturity, the milter that the sudden change of the second filial generation is grown up excises tail again with raun, reflects
Fixed, refer to step (6), obtain the Brachydanio rerio copulation again of identical mutation (lacking several base), thus the BMP2a that obtains isozygotying strikes
The Brachydanio rerio removed.
Comprise the steps: as the purification process in the present invention one optimal technical scheme, step (3) and step (4)
(A) adding water and the phenol/chloroform/isopropanol that volume is 1:2-3, after mixing, 10,000-15,000 rpm is centrifuged
5min. upper strata moves into new pipe, repeats this step once;
(B) upper strata moves into new pipe, adds 150ul chloroform, centrifugal 5 min;
(C) 1/10 volume 2.5 M sodium acetate and 2.5 volume ethanol ,-70C freezing 30min are added;
(D) centrifugal 10,000-15,000rpm is at 4C 15min;
(E) discard solution and stay precipitation, add 200ul 80% ethanol, centrifugal 5 min, discard solution, use 10-20 l after drying
DEPC H2O dissolves.
Claims (2)
1. the method being obtained by CRISPR/Cas9 knocking out the Brachydanio rerio of bmp2a gene, is comprised the steps:
(1) devising new gRNA sequence, design is BMP2a first between exon and intron, and gRNA sequence is
GGAGCCCATCACTAGACTCTTGG, enzyme action is HinfI;
(2) designing and synthesizing gRNA primer, primer is shown in Table 1:
The primer sequence of table 1 CAS9BMP2a is the P3 of design:
Forward sequence (5’to3’):CCTCTTCAACCTGACCTCCA;
Reverse sequence (5’to 3’):GTCCGTCTGTGGTCCACTTT;
P3:GATCACTAATACGACTCACTATAGGAGCCCATCACTAGACTCTGTTTTAGAGC TAGAAAT;
P4:AAAAGCACCGACTCGGTGCC;
GRNA sequence GGAGCCCATCACTAGACTCTTGG;
(3) primer of design being carried out PCR, PCR system is as follows:
gRNA- plasmid 10 ng;
P3 1 ul(10 pmol);
P4 1 ul(10 pmol);
Buffer 10;
dNTP 8;
KOD 0.5;
ddH2O Up to 100 ul;
PCR reaction condition is: 95 DEG C of denaturations 3min, enters three steps circulations (95 DEG C of-20s, 58 DEG C of-20s, 72 DEG C of-20s totally 30
Individual circulation), then 72 DEG C of-10min, finally it is incubated at 16 DEG C;After electrophoresis detection PCR primer, it is purified;
(4) under the conditions of RNA-Free, gRNA being carried out in vitro transcription, system is:
2.5mmol/L NTP 4ul;
10× Reaction Buffer 2ul;
Template DNA 1 1ug(<6ul);
T7 Enzyme Mix 2ul;
DEPC Water up to 20ul ;
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul ;
37 ° of C of above system, 1 hour reaction is complete, is then purified;
(5) being expelled in single celled zebrafish embryo by the mRNA of aforementioned purification, extract RNA after 4 days, transcription DNA is carried out
Order-checking detection;Injection system is as follows:
gRNA 12.5(ng/ul);
Cas9 300(ng/ul);
Tris-Hcl 0.2ul;
Phenol-red 0.2ul;
DEPC Water up to 2ul;
After (6) three months after sexual maturity, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, obtain the heterozygosis of certain probability
Son, will carry out RNA extraction and is transcribed into DNA and send order-checking to check whether sudden change after embryo, DNA at this time is also
It it is double-strand;Then after cDNA with the 19T carrier finding the Brachydanio rerio of sudden change after order-checking being connected, by it in culture medium
Middle ball chart board, after 12-14 hour, the plasmid connected can be grown up with spotwise, after being chosen speckle, obtains
It is the DNA of strand, again send order-checking, finally give the sudden change of strand, then cultivated sexual maturity after growing up three months
After, by the Brachydanio rerio hybridization of the Brachydanio rerio of sudden change with wild type, check whether sudden change after obtaining embryo, by the Brachydanio rerio of sudden change
Support after choosing monoclonal order-checking;
(7), after three months after sexual maturity, the milter that the sudden change of the second filial generation is grown up excises tail again with raun, reflects
Fixed, refer to step (6), obtain the Brachydanio rerio copulation again of identical mutation (lacking several base), thus the BMP2a that obtains isozygotying strikes
The Brachydanio rerio removed.
2. the method being obtained by CRISPR/Cas9 knocking out the Brachydanio rerio of bmp2a gene as claimed in claim 1, its feature
For;Purification process in step (3) and step (4) comprises the steps:
(A) adding water and the phenol/chloroform/isopropanol that volume is 1:2-3, after mixing, 10,000-15,000 rpm is centrifuged
5min. upper strata moves into new pipe, repeats this step once;
(B) upper strata moves into new pipe, adds 150ul chloroform, centrifugal 5 min;
(C) 1/10 volume 2.5 M sodium acetate and 2.5 volume ethanol ,-70C freezing 30min are added;
(D) centrifugal 10,000-15,000rpm is at 4C 15min;
(E) discard solution and stay precipitation, add 200ul 80% ethanol, centrifugal 5 min, discard solution, use 10-20 l after drying
DEPC H2O dissolves.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610637401.7A CN106282241A (en) | 2016-08-05 | 2016-08-05 | The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610637401.7A CN106282241A (en) | 2016-08-05 | 2016-08-05 | The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106282241A true CN106282241A (en) | 2017-01-04 |
Family
ID=57665155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610637401.7A Pending CN106282241A (en) | 2016-08-05 | 2016-08-05 | The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106282241A (en) |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107217075A (en) * | 2017-06-28 | 2017-09-29 | 西安交通大学医学院第附属医院 | A kind of method and primer, plasmid and preparation method of structure EPO gene knockout zebra fish animal models |
CN108018316A (en) * | 2017-12-20 | 2018-05-11 | 湖南师范大学 | A kind of method of gene knockout selection and breeding rmnd5b Gene Deletion zebra fish |
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
CN108707628A (en) * | 2018-05-28 | 2018-10-26 | 上海海洋大学 | The preparation method of zebra fish notch2 gene mutation bodies |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
CN108753833A (en) * | 2018-05-28 | 2018-11-06 | 上海海洋大学 | The preparation method of zebra fish notch3 gene mutation bodies |
CN108753834A (en) * | 2018-05-28 | 2018-11-06 | 上海海洋大学 | The preparation method of ddx27 gene delection zebra fish mutant |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
CN109207523A (en) * | 2017-06-29 | 2019-01-15 | 南京尧顺禹生物科技有限公司 | The foundation and application of human obesity's zebra fish model based on UCP1 gene |
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041857A2 (en) * | 2003-10-07 | 2005-05-12 | Quark Biotech, Inc. | Bone morphogenetic protein (bmp) 2a and uses thereof |
CN105274144A (en) * | 2015-09-14 | 2016-01-27 | 徐又佳 | Preparation method of zebrafish with hepcidin gene knocked out by use of CRISPR / Cas9 technology |
-
2016
- 2016-08-05 CN CN201610637401.7A patent/CN106282241A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041857A2 (en) * | 2003-10-07 | 2005-05-12 | Quark Biotech, Inc. | Bone morphogenetic protein (bmp) 2a and uses thereof |
CN105274144A (en) * | 2015-09-14 | 2016-01-27 | 徐又佳 | Preparation method of zebrafish with hepcidin gene knocked out by use of CRISPR / Cas9 technology |
Non-Patent Citations (1)
Title |
---|
ZHAOMIN ZHONG ET AL: "Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp", 《SCIENTIFIC REPORTS》 * |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US11920181B2 (en) | 2013-08-09 | 2024-03-05 | President And Fellows Of Harvard College | Nuclease profiling system |
US10954548B2 (en) | 2013-08-09 | 2021-03-23 | President And Fellows Of Harvard College | Nuclease profiling system |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US11299755B2 (en) | 2013-09-06 | 2022-04-12 | President And Fellows Of Harvard College | Switchable CAS9 nucleases and uses thereof |
US10912833B2 (en) | 2013-09-06 | 2021-02-09 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US10682410B2 (en) | 2013-09-06 | 2020-06-16 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US11124782B2 (en) | 2013-12-12 | 2021-09-21 | President And Fellows Of Harvard College | Cas variants for gene editing |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US11578343B2 (en) | 2014-07-30 | 2023-02-14 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US11214780B2 (en) | 2015-10-23 | 2022-01-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US11702651B2 (en) | 2016-08-03 | 2023-07-18 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10947530B2 (en) | 2016-08-03 | 2021-03-16 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11820969B2 (en) | 2016-12-23 | 2023-11-21 | President And Fellows Of Harvard College | Editing of CCR2 receptor gene to protect against HIV infection |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
CN107217075A (en) * | 2017-06-28 | 2017-09-29 | 西安交通大学医学院第附属医院 | A kind of method and primer, plasmid and preparation method of structure EPO gene knockout zebra fish animal models |
CN107217075B (en) * | 2017-06-28 | 2021-07-02 | 西安交通大学医学院第一附属医院 | Method for constructing EPO gene knockout zebra fish animal model, primer, plasmid and preparation method |
CN109207523A (en) * | 2017-06-29 | 2019-01-15 | 南京尧顺禹生物科技有限公司 | The foundation and application of human obesity's zebra fish model based on UCP1 gene |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11932884B2 (en) | 2017-08-30 | 2024-03-19 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
CN108018316A (en) * | 2017-12-20 | 2018-05-11 | 湖南师范大学 | A kind of method of gene knockout selection and breeding rmnd5b Gene Deletion zebra fish |
CN108707628B (en) * | 2018-05-28 | 2021-11-23 | 上海海洋大学 | Preparation method of zebra fish notch2 gene mutant |
CN108753834A (en) * | 2018-05-28 | 2018-11-06 | 上海海洋大学 | The preparation method of ddx27 gene delection zebra fish mutant |
CN108753833A (en) * | 2018-05-28 | 2018-11-06 | 上海海洋大学 | The preparation method of zebra fish notch3 gene mutation bodies |
CN108753834B (en) * | 2018-05-28 | 2021-11-23 | 上海海洋大学 | Preparation method of zebra fish mutant with ddx27 gene deletion |
CN108707628A (en) * | 2018-05-28 | 2018-10-26 | 上海海洋大学 | The preparation method of zebra fish notch2 gene mutation bodies |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11795452B2 (en) | 2019-03-19 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11643652B2 (en) | 2019-03-19 | 2023-05-09 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106282241A (en) | The method obtaining knocking out the Brachydanio rerio of bmp2a gene by CRISPR/Cas9 | |
CN105274144A (en) | Preparation method of zebrafish with hepcidin gene knocked out by use of CRISPR / Cas9 technology | |
CN107475300B (en) | Construction method and application of Ifit3-eKO1 gene knockout mouse animal model | |
CN106318934B (en) | Gene complete sequence of carrot β (1,2) xylose transferase and plasmid construction of CRISPR/CAS9 for transfecting dicotyledonous plants | |
CN106916820B (en) | SgRNA and its application of porcine ROSA 26 gene can effectively be edited | |
CN107326046A (en) | A kind of method for improving foreign gene homologous recombination efficiency | |
CN103343120A (en) | Wheat genome site-specific modification method | |
CN108546716A (en) | A kind of genome edit methods | |
CN104342457A (en) | Method for targetedly integrating exogenous gene into target gene | |
CN106701830A (en) | Method for knocking out p66shc gene in pig embryo | |
CN105821075A (en) | Establishment method of caffeine synthetase CRISPR/Cas9 genome editing vector | |
CN107446922A (en) | A kind of gRNA sequences and its application method for knocking out hepcidin gene in human osteoblast cell's strain | |
CN104531705A (en) | Method for knocking off animal myostatin gene by using CRISPR-Cas9 system | |
CN105985943A (en) | Method for site transformation on plant genome by using non-genetic material | |
AU2017101108A4 (en) | Construction method of animal model of mucopolysaccharidosis type II and use thereof | |
CN110643636B (en) | Megalobrama amblycephala MSTNa & b gene knockout method and application | |
CN102653756B (en) | Directional modification method of specific gene of animal genome and application thereof | |
CN105274141A (en) | Transgenic vector for target mutation of primordial germ cells, method for preparing transgenic vector and application thereof | |
CN105505879A (en) | Method and culture medium for culturing transgenic animal embryonic cells or transgenic animals | |
CN109402170B (en) | Method for establishing fish male sterility model | |
CN108893495B (en) | Construction method of Pdzd7 gene mutation animal model | |
CN110066805A (en) | The method of gene knockout breeding adgrf3b Gene Deletion zebra fish | |
CN108300738B (en) | Preparation method of humanized mouse model with NOD genetic background and neutrophilic granulocyte deletion | |
CN109652457A (en) | A kind of method of gene knockout breeding ALPK2 Gene Deletion zebra fish | |
CN104212837B (en) | Lentiviral vector for expression of human serum albumin and construction method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
RJ01 | Rejection of invention patent application after publication |